Treatment News : HIV Tests Are Needed Much More Frequently Than the CDC Advises

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » March 2013

Most Popular Links
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

March 26, 2013

HIV Tests Are Needed Much More Frequently Than the CDC Advises

Significantly raising the frequency of HIV tests would benefit both high- and low-risk groups and prove cost-effective as well, according to research from Northwestern University. Publishing their findings in the journal AIDS, investigators conducted mathematical modeling to determining what the best frequencies for HIV screens would be among high-risk (those with an annual incidence of 1.0 percent or more), moderate-risk (0.1 percent incidence) and low-risk (0.01 percent incidence) groups. They based their calculations on the assumption that newly diagnosed people would enter treatment immediately—otherwise known as “test-and-treat.”

Currently, the Centers for Disease Control and Prevention (CDC) advises that high-risk groups, including those with HIV-positive or multiple partners, injection drug users and sex workers, undergo annual HIV tests. Low-risk groups are advised to test once in a lifetime. The CDC does not distinguish moderate-risk groups in their recommendations. 

The investigators at Northwestern deduced that the optimal frequency for testing among high-risk groups is every three months, for moderate-risk every nine months, and low-risk about every two and a half years. They found that the extra tests would come at “a relatively low cost to society.”

The paper concludes that “[t]he current CDC guidelines for HIV testing are too conservative, and more frequent testing is cost-effective for all risk groups.”
 
To read the release, click here.

To read the study, click here.

Search: HIV, test, screen, frequency, CDC, Centers for Disease Control and Prevention, AIDS, cost-effective, test-and-treat, high-risk, moderate-risk, low-risk.


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Hide comments

Previous Comments:


         


[Go to top]


Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    Drew949
    South Orange County
    California


    juliar33
    brooklyn
    New York


    cortaza100
    Oakland
    California


    jap022964
    el dorado
    Arkansas
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Are you a regular coffee drinker?
Yes
No

Survey
Pop Watch

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.